A kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival

Journal of Virology

Volumn 86, Issue 21, 2012, Pages 11698-11711

  Lei, Xiufen ^a   Zhu, Ying ^b   Jones, Tiffany ^a,b   Bai, Zhiqiang ^a   Huang, Yufei ^c   Gao, Shou Jiang ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c The University of Texas at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 142 3P; MICRORNA K10A; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; GENE TARGETING; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; KAPOSI SARCOMA; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS PATHOGENESIS;

APOPTOSIS; CELL LINE; CELL SURVIVAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNE EVASION; MICRORNAS; RNA, VIRAL; TRANSFORMING GROWTH FACTOR BETA;

HUMAN HERPESVIRUS 8;

EID: 84869074612     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06855-11     Document Type: Article

References (53)

1. Abend JR, Uldrick T, Ziegelbauer JM. 2010. Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J. Virol.84:12139-12151.
2. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.
3. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
4. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
5. Bellare P, Ganem D. 2009. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6:570-575.
6. Bierie B, Moses HL. 2006. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6:506-520.
7. Cai X, Cullen BR. 2006. Transcriptional origin of Kaposi's sarcomaassociated herpesvirus microRNAs. J. Virol. 80:2234-2242.
8. Cai X, et al. 2005. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. U.S.A. 102:5570-5575.
9. Chen G, Ghosh P, Longo DL. 2011. Distinctive mechanism for sustained TGF-beta signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-beta receptors. Mol. Cancer Res. 9:78-89.
10. Cheng PL, Chang MH, Chao CH, Lee YH. 2004. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation. Oncogene 23:7821-7838.
11. Ciernik IF, et al. 1995. Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma. Clin. Cancer Res. 1:1119-1124.
12. Cullen BR. 2009. Viral and cellular messenger RNA targets of viral microRNAs. Nature 457:421-425.
13. Di Bartolo DL, et al. 2008. KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood 111: 4731-4740.
14. Gao SJ, et al. 1996. Seroconversion to antibodies against Kaposi's sarcoma- associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N. Engl. J. Med. 335:233-241.
15. Gottwein E, Cai X, Cullen BR. 2006. A novel assay for viral microRNA function identifies a single nucleotide polymorphism that affects Drosha processing. J. Virol. 80:5321-5326.
16. Gottwein E, et al. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10:515-526.
17. Gottwein E, Cullen BR. 2010. A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J. Virol. 84:5229-5237.
18. Gottwein E, et al. 2007. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450:1096-1099.
19. Grundhoff A, Sullivan CS, Ganem D. 2006. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12:733-750.
20. Inman GJ, Allday MJ. 2000. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines. J. Gen. Virol. 81:1567-1578.
21. Lee DK, Kim BC, Brady JN, Jeang KT, Kim SJ. 2002. Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element. J. Biol. Chem. 277:33766-33775.
22. Lee DK, et al. 2002. The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence. J. Biol. Chem. 277: 38557-38564.
23. Lei X, et al. 2010. Regulation of NF-kappaB inhibitor IκBα and viral replication by a KSHV microRNA. Nat. Cell Biol. 12:193-199.
24. Levy L, Hill CS. 2006. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17:41-58.
25. Liang D, et al. 2011. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKepsilon. Cell Res. 21:793- 806.
26. Lin X, et al. 2011. miR-K12-7-5p encoded by Kaposi's sarcomaassociated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS One 6:e16224. doi:10.1371/journal.pone.0016224.
27. Lin YT, et al. 2010. Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs. RNA 16:1540-1558.
28. Liu H, Yue D, Chen Y, Gao SJ, Huang Y. 2010. Improving performance of mammalian microRNA target prediction. BMC Bioinformatics 11:476. doi:10.1186/1471-2105-11-476.
29. Liu Y, et al. 2012. Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. J. Virol. 86:1372-1381.
30. Louafi F, Martinez-Nunez RT, Sanchez-Elsner T. 2010. MicroRNA-155 targetsSMAD2and modulates the response of macrophages to transforming growth factor-β. J. Biol. Chem. 285:41328-41336.
31. Lu CC, et al. 2010. MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle. EMBO Rep. 11:784-790.
32. Lu F, Stedman W, Yousef M, Renne R, Lieberman PM. 2010. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virusencoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 84:2697-2706.
33. Massague J. 2008. TGFβ in Cancer. Cell 134:215-230.
34. Mori N, et al. 2001. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300. Blood 97:2137-2144.
35. Mori N, Morishita M, Tsukazaki T, Yamamoto N. 2003. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB. Int.J. Cancer 105:661-668.
36. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O. 2009. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5:376-385.
37. Pfeffer S, et al. 2005. Identification of microRNAs of the herpesvirus family. Nat. Methods 2:269-276.
38. Qin Z, et al. 2010. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog. 6:e1000742. doi:10.1371/journal.ppat.1000742.
39. Qin Z, Kearney P, Plaisance K, Parsons CH. 2010. Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J. Leukoc. Biol. 87:25-34.
40. Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC. 2010. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc. Natl. Acad. Sci. U.S.A. 107:3111-3116.
41. Samols MA, Hu J, Skalsky RL, Renne R. 2005. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79:9301-9305.
42. Samols MA, et al. 2007. Identification of cellular genes targeted by KSHVencoded microRNAs.PLoSPathog. 3:e65. doi:10.1371/journal.ppat.0030065.
43. Schmierer B, Hill CS. 2007. TGFβ-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8:970-982.
44. Seo T, Park J, Choe J. 2005. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.Cancer Res. 65:1738-1747.
45. Shankarappa B, Balachandran R, Gupta P, Ehrlich GD. 1992. Introduc-tion of multiple restriction enzyme sites by in vitro mutagenesis using the polymerase chain reaction. PCR Methods Appl. 1:277-278.
46. Skalsky RL, et al. 2007. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81:12836-12845.
47. Tarakanova VL, Wold WS. 2003. Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells. J. Virol. 77:9324-9336.
48. Tomita M, Choe J, Tsukazaki T, Mori N. 2004. The Kaposi's sarcomaassociated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein. Oncogene 23:8272-8281.
49. Umbach JL, Cullen BR. 2010. In-depth analysis of Kaposi's sarcomaassociated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery. J. Virol. 84:695-703.
50. Wu MY, Hill CS. 2009. Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev. Cell 16:329-343.
51. Ye F, Lei X, Gao SJ. 2011. Mechanisms of Kaposi's sarcoma-associated herpesvirus latency and reactivation. Adv. Virol. 2011:193860. doi:10.1155/2011/193860.
52. Zawel L, et al. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1:611-617.
53. Ziegelbauer JM, Sullivan CS, Ganem D. 2009. Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs. Nat.Genet. 41:130-134.